We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

BioLife Solutions Inc (BLFS) USD0.001

Sell:$26.01 Buy:$30.00 Change: $1.28 (4.90%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$26.01
Buy:$30.00
Change: $1.28 (4.90%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$26.01
Buy:$30.00
Change: $1.28 (4.90%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

Contact details

Address:
SUITE 310, 3303 MONTE VILLA PARKWAY
BOTHELL
98021
United States
Telephone:
+1 (425) 4011400
Website:
https://www.biolifesolutions.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BLFS
ISIN:
US09062W2044
Market cap:
$1.15 billion
Shares in issue:
46.23 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Roderick De Greef
    Chairman of the Board, Chief Executive Officer
  • Troy Wichterman
    Chief Financial Officer
  • Sarah Aebersold
    Chief Human Resource Officer
  • Aby Mathew
    Chief Scientific Officer, Executive Vice President
  • Geraint Phillips
    Senior Vice President - Global Operations
  • Todd Berard
    Chief Marketing Officer
  • Karen Foster
    Chief Quality and Operations Officer
  • Garrie Richardson
    Chief Revenue Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.